| Drugs by Condition |  |
Atrial Fibrillation
Definition: A condition where there is disorganised electrical conduction in the atria, resulting in ineffective pumping of blood into the ventricle.
Acronym: AF
Drugs associated with Atrial Fibrillation
The following drugs and medications are in some way related to, or used in the treatment of Atrial Fibrillation.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Atrial Fibrillation Related Drugs in the Pipeline
Kynapid (vernakalant)
- January 22, 2008
Cardiome And Astellas Announce Kynapid Regulatory Update - December 12, 2007
FDA Advisory Committee Recommends Approval of Kynapid for Acute Atrial Fibrillation - August 30, 2007
Cardiome And Astellas Announce Regulatory Extension - February 19, 2007
Cardiome And Astellas Announce Acceptance Of NDA For Review - December 18, 2006
Cardiome and Astellas Pharma US, Inc. Announce Re-Submission of NDA for Vernakalant (IV) - May 31, 2006
Cardiome Announces Refusal to File Decision By the FDA - March 31, 2006
New Drug Application Submitted For RSD1235
Pulzium (tedisamil)
- December 13, 2007
Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation - September 26, 2007
Solvay Pharmaceuticals, Inc. Announces FDA Extension of Tedisamil PDUFA Date - April 25, 2007
Solvay Pharmaceuticals Files Tedisamil, a New Cardiometabolic Product for the Treatment of Atrial Fibrillation and Atrial Flutter
See also
Learn more about Atrial Fibrillation
Medical encyclopedia results for:
